Showing results (161-170 of 344) with videos related to

Sort By:
Pageof 35
EMBO Molecular Medicine|March 13, 2020
Adeno-associated virus-vectored influenza vaccine elicits neutralizing and Fcγ receptor-activating antibodiesDaniel E Demminger, Lisa Walz, Kristina Dietert, et al.
Virus Research|January 11, 2011
Nuclear localization of influenza B polymerase proteins and their binary complexesQiji Deng, Dan Wang, Xiaoxiao Xiang, et al.
Infection and Immunity|September 16, 2015
Pulmonary immunostimulation with MALP-2 in influenza virus-infected mice increases survival after pneumococcal superinfectionKatrin Reppe, Peter Radünzel, Kristina Dietert, et al.
The Journal of General Virology|January 15, 2009
Influenza B mutant viruses with truncated NS1 proteins grow efficiently in Vero cells and are immunogenic in miceNina Wressnigg, Anna Polina Shurygina, Thorsten Wolff, et al.
Plos Pathogens|September 13, 2011
Influenza virus ribonucleoprotein complexes gain preferential access to cellular export machinery through chromatin targetingGeoffrey P Chase, Marie-Anne Rameix-Welti, Aurelija Zvirbliene, et al.
The Journal of Biological Chemistry|July 17, 2009
MEK5/ERK5 signaling modulates endothelial cell migration and focal contact turnoverDésirée Spiering, Mirco Schmolke, Nils Ohnesorge, et al.
Journal of Innate Immunity|March 1, 2013
Highly pathogenic influenza viruses inhibit inflammatory response in monocytes via activation of rar-related orphan receptor RORαJudith Friesenhagen, Dorothee Viemann, Yvonne Börgeling, et al.
Antiviral Research|March 4, 2024
The host-targeted antiviral drug Zapnometinib exhibits a high barrier to the development of SARS-CoV-2 resistanceAndré Schreiber, Franziska Rodner, Nicole Oberberg, et al.
Expert Review of Anti-Infective Therapy|October 1, 2013
Pathogenesis of Staphylococcus aureus necrotizing pneumonia: the role of PVL and an influenza coinfectionBettina Löffler, Silke Niemann, Christina Ehrhardt, et al.
Pageof 35